NM_024675.4(PALB2):c.508A>C (p.Arg170=) AND Hereditary cancer-predisposing syndrome
- Germline classification:
- Likely benign (2 submissions)
- Last evaluated:
- Nov 25, 2021
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV000771725.5
Allele description [Variation Report for NM_024675.4(PALB2):c.508A>C (p.Arg170=)]
NM_024675.4(PALB2):c.508A>C (p.Arg170=)
Condition(s)
- Name:
- Hereditary cancer-predisposing syndrome
- Synonyms:
- Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
- Identifiers:
- MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672
-
PREDICTED: Homo sapiens integrin subunit alpha 2b (ITGA2B), transcript variant X...
PREDICTED: Homo sapiens integrin subunit alpha 2b (ITGA2B), transcript variant X2, mRNAgi|2462554936|ref|XM_054315957.1|Nucleotide
-
Human DNA sequence from clone RP3-526N11 on chromosome 6, complete sequence
Human DNA sequence from clone RP3-526N11 on chromosome 6, complete sequencegi|11322849|emb|AL365193.12|Nucleotide
-
PREDICTED: Aptenodytes forsteri galactose-3-O-sulfotransferase 1 (GAL3ST1), tran...
PREDICTED: Aptenodytes forsteri galactose-3-O-sulfotransferase 1 (GAL3ST1), transcript variant X2, mRNAgi|1111005519|ref|XM_009280109.2|Nucleotide
-
PREDICTED: Momordica charantia uncharacterized LOC111018155 (LOC111018155), mRNA
PREDICTED: Momordica charantia uncharacterized LOC111018155 (LOC111018155), mRNAgi|1229792503|ref|XM_022294118.1|Nucleotide
-
MSMAW_RS19315 [Methanosarcina mazei WWM610]
MSMAW_RS19315 [Methanosarcina mazei WWM610]Gene ID:77092832Gene
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Sep 29, 2024